Concepedia

Katharina Lankes

KL

Statistics

Publications

4

Citations

186

H-Index

4

Active since

2016

Affiliations

Heidelberg University(Current)

German Cancer Research Center

Deutsches Konsortium für Translationale Krebsforschung

Technical University of Munich

Center for Integrated Protein Science Munich

Katharina Lankes is an author at Heidelberg University specializing in oncology, oncogenic signaling pathways, and molecular oncology.

Publications per year

2016–2022

4

Publications

4

Anti-TNF-refractory colitis after checkpoint inhibitor therapy: Possible role of CMV-mediated immunopathogenesis

Katharina Lankes, Gheorghe Hundorfean, Thomas Harrer et al. · OncoImmunology · 2016 · 85 citations · Full text

, , +17

HDAC2 Facilitates Pancreatic Cancer Metastasis

Lukas Krauß, Bettina C. Urban, Sieglinde Hastreiter et al. · Cancer Research · 2021 · 48 citations · Full text

, , +11

Epigenetic drug screening defines a PRMT5 inhibitor–sensitive pancreatic cancer subtype

Felix Orben, Katharina Lankes, Christian Schneeweis et al. · JCI Insight · 2022 · 30 citations · Full text

, , +17

Targeting the ubiquitin‐proteasome system in a pancreatic cancer subtype with hyperactive MYC

Katharina Lankes, Zonera Hassan, María Josefina Doffo et al. · Molecular Oncology · 2020 · 23 citations · Full text

, , +17

1–4 of 4